Publication Archive - Epiconcept

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.

Bergeri I, Whelan MG, Ware H, Subissi L, Nardone A, Lewis HC, Li Z, Ma X, Valenciano M, Cheng B, Al Ariqi L, Rashidian A, Okeibunor J, Azim T, Wijesinghe P, Le LV, Vaughan A, Pebody R, Vicari A, Yan T, Yanes-Lane M, Cao C, Clifton DA, Cheng MP, Papenburg J, Buckeridge D, Bobrovitz N, Arora RK, Van Kerkhove MD; Unity Studies Collaborator Group.

PLoS Med. 2022 Nov 10;19(11):e1004107. doi: 10.1371/journal.pmed.1004107. PMID: 36355774; PMCID: PMC9648705.

Available here

European Centre for Disease Prevention and Control. Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 20 years and older, ECDC multi-country study – third update

European Centre for Disease Prevention and Control.

ECDC: Stockholm; 2022 November 8.

Available here

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.

Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B,We Celentano LP, Hanquet G; SpIDnet group.

Lancet Respir Med. 2017 Aug;5(8):648-656. doi: 10.1016/S2213-2600(17)30110-8. Epub 2017 Mar 27. PMID: 28359798.

Available here

COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data.

Sridhar S, Fico A, Preza I, Hatibi I, Sulo J, Kissling E, Daja R, Ibrahim R, Lemos D, Rubin-Smith J, Schmid A, Vasili A, Valenciano M, Jorgensen P, Pebody R, Lafond KE, Katz MA, Bino S.

BMJ Open 2022;12:e057741. doi: 10.1136/bmjopen-2021-057741

Available here

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.

Kissling Esther, Hooiveld Mariëtte, Martínez-Baz Iván, Mazagatos Clara, William Naoma, Vilcu Ana-Maria, Kooijman Marjolein N, Ilić Maja, Domegan Lisa, Machado Ausenda, de Lusignan Simon, Lazar Mihaela, Meijer Adam, Brytting Mia, Casado Itziar, Larrauri Amparo, Murray Josephine-L K, Behillil Sylvie, de Gier Brechje, Mlinarić Ivan, O’Donnell Joan, Rodrigues Ana Paula, Tsang Ruby, Timnea Olivia, de Lange Marit, Riess Maximilian, Castilla Jesús, Pozo Francisco, Hamilton Mark, Falchi Alessandra, Knol Mirjam J, Kurečić Filipović Sanja, Dunford Linda, Guiomar Raquel, Cogdale Jade, Cherciu Carmen, Jansen Tessa, Enkirch Theresa, Basile Luca, Connell Jeff, Gomez Verónica, Sandonis Martín Virginia, Bacci Sabrina, Rose Angela MC, Pastore Celentano Lucia, Valenciano Marta, I-MOVE-COVID-19 and ECDC primary care study teams.

Euro Surveill. 2022;27(21):pii=2101104.

Available here

Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned.

Bagaria Jayshree, Jansen Tessa, Marques Diogo FP, Hooiveld Mariette, McMenamin Jim, de Lusignan Simon, Vilcu Ana-Maria, Meijer Adam, Rodrigues Ana-Paula, Brytting Mia, Mazagatos Clara, Cogdale Jade, van der Werf Sylvie, Dijkstra Frederika, Guiomar Raquel, Enkirch Theresa, Valenciano Marta, I-MOVE-COVID-19 study team

Euro Surveill. 2022;27(26):pii=2100864.

Available here

Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother’s vaccination in pregnancy in infants aged 2-11 months. Vaccine. 2022 Oct 19;40(44):6374-6382. doi: 10.1016/j.vaccine.2022.09.054. Epub 2022 Sep 29. PMID: 36182617; PMCID: PMC9589240.

Merdrignac L, Acosta L, Habington A, Garcìa Cenoz M, Pandolfi E, Fabiánová K, Jordan I, O’Sullivan N, Navasués A, Tozzi AE, Zavadilová J, Jané M, Cotter S, Pitillas NI, Rizzo C, Křížová P, Hanslik T, Muñoz Almagro C, Pastore L, Bacci S, Moren A, Valenciano M; PERTINENT Group.

Available here

COVID-19 vaccine effectiveness estimation using the screening method Operational tool for countries.

Available here

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries Europe

Hanquet G., Krizova P., Dalby T., Ladhani S.N., Nuorti J.P., Danis K., Mereckiene J., Knol M.J., Winje B.A., Ciruela P., de Miguel S., Portillo M.E., MacDonald L., Morfeldt E., Kozakova J., Valentiner-Branth P., Fry N.K., Rinta-Kokko H., Varon E., Corcoran M., van der Ende A., Vestrheim D.F., Munoz-Almagro C., Sanz J-C., Castilla J., Smith A., Henriques-Normark H., Colzani E., Pastore-Celentano L., Savulescu C., the SpIDnet group

Emerg. Infect. Dis. 2022;28:137–138. doi: 10.3201/eid2801.210734.

I-MOVE/I-MOVE+ study team, 2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children.

Kissling E, Valenciano M, Pozo F, Vilcu A-M, Reuss A, Rizzo C, et al

Influenza Other Resp Viruses. Accepted Author Manuscript.doi:10.1111/irv.125207

Publication

Référencement Centrales d'achats

Hébergement de données de santé

Engagement et éthique